AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 0.78% to $146.60 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.05% to 4,119.21 and the Dow Jones Industrial Average rising 0.02% to 34,092.96. AbbVie Inc. closed $29.31 below its 52-week high ($175.91), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.92% to $164.92 and Pfizer Inc. (PFE) fell 0.43% to $43.97. Trading volume (5.3 M) remained 104,721 below its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 1, 2023.
(END) Dow Jones Newswires
February 01, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.